Literature DB >> 31489614

Paediatric-onset neuronal ceroid lipofuscinosis: first symptoms and presentation at diagnosis.

Blandine Dozières-Puyravel1, Hala Nasser1, Monique Elmaleh-Bergès1, Elisa Lopez Hernandez1, Antoinette Gelot2, Adina Ilea1, Catherine Delanoë1, Jean-Philippe Puech3, Catherine Caillaud3, Samia Pichard1, Stéphane Auvin1.   

Abstract

Neuronal ceroid lipofuscinoses (NCLs) are rare, progressive disorders. Through this series of 20 patients with NCL, we illustrate differences between subtypes in their presenting symptoms and clinical, imaging, and electrophysiological results to raise awareness of symptom diversity. Data were available on presenting symptoms, genetics, magnetic resonance imaging (MRI), electroencephalography (including with low-frequency intermittent photic stimulation), visual responses, and electron microscopy. Causal mutations were identified in 10 patients. Eleven patients had neuronal ceroid lipofuscinosis type 2 (CLN2) disease and their most common presenting symptom was seizures, although motor and language defects were also reported. Five patients with CLN2 disease showed abnormalities at initial MRI, but only three showed a photic response with low-frequency stimulation. Seizures were not as common a presenting symptom in other NCL subtypes. Patients with NCLs present with diverse symptoms, which may not be characteristic in early disease stages. These signs and symptoms should lead to rapid diagnostic confirmatory testing for NCLs. WHAT THIS PAPER ADDS: Disease presentation is not uniform for neuronal ceroid lipofuscinoses. Characteristic clinical test results may not be identified in early disease stages.
© 2019 Mac Keith Press.

Entities:  

Mesh:

Year:  2019        PMID: 31489614     DOI: 10.1111/dmcn.14346

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  7 in total

Review 1.  Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis.

Authors:  Konrad Kaminiów; Sylwia Kozak; Justyna Paprocka
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

Review 2.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

3.  Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfa.

Authors:  J Schaefers; L J van der Giessen; C Klees; E H Jacobs; S Sieverdink; M H G Dremmen; J K H Spoor; A T van der Ploeg; J M P van den Hout; H H Huidekoper
Journal:  Orphanet J Rare Dis       Date:  2021-05-14       Impact factor: 4.123

4.  Child with predominant midline stereotypies and infrequent seizures.

Authors:  Bhanudeep Singanamalla; Priyanka Madaan; Lokesh Saini; Naveen Sankhyan
Journal:  BMJ Case Rep       Date:  2021-01-20

Review 5.  Neurophysiological Findings in Neuronal Ceroid Lipofuscinoses.

Authors:  Marina Trivisano; Alessandro Ferretti; Costanza Calabrese; Nicola Pietrafusa; Ludovica Piscitello; Giusy Carfi' Pavia; Federico Vigevano; Nicola Specchio
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

6.  The LINCE Project: A Pathway for Diagnosing NCL2 Disease.

Authors:  Daniel Rodrigues; Maria José de Castro; Pablo Crujeiras; Anna Duat-Rodriguez; Ana Victoria Marco; Mireia Del Toro; María L Couce; Cristóbal Colón
Journal:  Front Pediatr       Date:  2022-03-29       Impact factor: 3.418

7.  An ERG and OCT study of neuronal ceroid lipofuscinosis CLN2 Battens retinopathy.

Authors:  Dorothy A Thompson; Siân E Handley; Robert H Henderson; Oliver R Marmoy; Paul Gissen
Journal:  Eye (Lond)       Date:  2021-07-16       Impact factor: 3.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.